Biobot Analytics Funding & Investors
Cambridge, MA
Biobot Analytics is an American biotechnology company that specializes in wastewater-based epidemiology headquartered in Cambridge, Massachusetts. The company analyzes wastewater samples to measure the concentration of various substances, including pathogens, illicit drugs, and other public health indicators. Biobot was founded in 2017 at MIT by computational biologist Mariana Matus and architect Newsha Ghaeli.
biobot.ioTotal Amount Raised: $41,398,736
Biobot Analytics' Investors
Biobot Analytics Funding Rounds
Series A
$13,400,000
Series A Investors
VALORAtreides ManagementHyperplaneSeries A
$20,833,737
Series A Investors
Thursday VenturesHalf Court VenturesSeed
$4,200,000
Seed Investors
The EngineDCVCY CombinatorAmerican Family Insurance Institute for Corporate and Social ImpactBlindspot VenturesSeed
$2,500,000
Seed Investors
Sinai Capital PartnersDCVCPathbreaker VenturesRefactor CapitalLiquid 2 VenturesSoma CapitalPioneer FundEmmett ShearJake GibsonJuha PaananenMarc McCabeEkistic VenturesBragiel BrothersMark SciannaBrad FloraHalf Court VenturesPre Seed
$120,000
Pre Seed Investors
Y CombinatorLiquid 2 VenturesPre Seed
$345,000
Pre Seed Investors
HomebrewHyperplaneDorm Room FundGeneral Catalyst
Funding info provided by Diffbot.